1. Home
  2. AEHR vs DSGN Comparison

AEHR vs DSGN Comparison

Compare AEHR & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$82.22

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

HOLD

Current Price

$11.13

Market Cap

819.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
DSGN
Founded
1977
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
819.6M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
AEHR
DSGN
Price
$82.22
$11.13
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$29.50
$15.25
AVG Volume (30 Days)
2.9M
957.8K
Earning Date
04-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,968,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$71.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.43
$3.33
52 Week High
$108.75
$17.25

Technical Indicators

Market Signals
Indicator
AEHR
DSGN
Relative Strength Index (RSI) 47.46 39.39
Support Level $76.71 $9.25
Resistance Level $102.48 $13.54
Average True Range (ATR) 11.19 1.39
MACD -3.32 -0.52
Stochastic Oscillator 16.74 15.90

Price Performance

Historical Comparison
AEHR
DSGN

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Share on Social Networks: